Satellite Symposia Agenda
Satellite Symposium MSD | Redefining discussions in the management of melanoma patients
Wednesday, April 24th 2019 | 16:30 - 17:30 | AMPHITHEATRE LAVOISIER - Level 1
Chairs: Caroline ROBERT (France), Peter MOHR (Germany)
- Introduction - Caroline ROBERT (France), Peter MOHR (Germany)
- How is long term survival in advanced melanoma shaping our practice? - Helen GOGAS (Greece)
- Questions & answers and panel discussion- Caroline ROBERT (France), Peter MOHR (Germany)
- How have recent advances in adjuvant treatment of melanoma altered the patient journey? - Olivier MICHIELIN (Switzerland)
- Questions & answers and panel discussion- Caroline ROBERT (France), Peter MOHR (Germany)
- Closing remarks - Caroline ROBERT (France)
Satellite Symposium BRISTOL-MYERS SQUIBB | Perspectives on melanoma: present challenges and future considerations
Thursday, April 25th 2019 | 13:00 - 14:00 | AMPHITHEATRE LAVOISIER - Level 1
Chair: Caroline ROBERT (France)
- Welcome and introduction - Caroline ROBERT (France)
- Expert insights into patient management - Peter MOHR (Germany)
- Sequencing strategies in melanoma - James LARKIN (United Kingdom)
- Immuno-oncology in melanoma: an interactive discussion - Caroline ROBERT (France)
- Summary and close - Caroline ROBERT (France)
Satellite Symposium NOVARTIS | Targeted adjuvant therapy in melanoma, COMBIning our knowledge on cure-rate models and treatment-related decisions
Thursday, April 25th 2019 | 15:00 - 16:00 | PETIT AMPHITHEATRE - Level 0
Chair: Céleste LEBBE (France)
- Welcome and introduction - Céleste LEBBE (France)
- Clinical evidence for targeted therapy of adjuvant melanoma patients and lessons from the cure-rate model - Axel HAUSCHILD (Germany)
- Beyond efficacy: What treatment-related factors should be considered? - Jean-Jacques GROB (France)
- Hot topics in adjuvant therapy – panel discussion and Q&A - Céleste LEBBE (France)
- Chair’s wrap-up and close - Céleste LEBBE (France)
Satellite Symposium HELSINN / RECORDATI RARE DISEASES | Chlormethine gel and MF-CTCL: exploring the real-world evidence
Thursday, April 25th 2019 | 18:00 - 19:00 | AMPHITHEATRE LAVOISIER - Level 1
Chairs: Martine BAGOT (France), Ellen J. KIM (USA)
- Opening and welcome - Martine BAGOT (France)
- MF-CTCL management: the real-world evidence of chlormethine gel in North America (PROVe trial) - Ellen J. KIM (USA)
- A topical therapy for all stages? Real-world evidence of chlormethine gel in late-stage MF-CTCL - Martine BAGOT (France)
- Q&A session and closing: your views on chlormethine gel in early- and late-stage MFCTCL - Ellen J. KIM (USA), Martine BAGOT (France)
Satellite Symposium PIERRE FABRE | Patients’ cases in the evolving landscape of BRAF-mutant metastatic melanoma
Friday, April 26th 2019 | 13:00 - 14:00 | AMPHITHEATRE LAVOISIER - Level 1
Chairs: Céleste LEBBE (France), Axel HAUSCHILD (Germany)
- Welcome and introductions - Céleste LEBBE (France)
- Clinical trials Experience - Paolo ASCIERTO (Italy)
- Real life clinical case with Encorafenib + Binimetinib - Christoffer GEBHARDT (Germany)
- Discussion - Céleste LEBBE (France), Axel HAUSCHILD (Germany), Paolo ASCIERTO (Italy), Christoffer GEBHARDT (Germany)
- Conclusions - Axel HAUSCHILD (Germany)
Satellite Symposium ROCHE | Building on experience: optimising treatment outcomes for patients with advanced basal cell carcinoma
Friday, April 26th 2019 | 15:30 - 16:30 | PETIT AMPHITHEATRE - Level 0
Chair: Nicole BASSET-SÉGUIN (France)
- Welcome and introduction - Nicole BASSET-SÉGUIN (France)
- Experience in the treatment of advanced BCC - Nicole BASSET-SÉGUIN (France)
- Managing patients with advanced BCC: interactive patient cases - Dirk SCHADENDORF (Germany), Laurent MORTIER (France), Nicole BASSET-SÉGUIN (France)
- Building on experience: optimising treatment outcomes - Laurent MORTIER (France)
- Closing remarks - Nicole BASSET-SÉGUIN (France)
Satellite Symposium SANOFI GENZYME/REGENERON | Managing Advanced CSCC in 2019: Cases & Conversations
Friday, April 26th 2019 | 15:30 - 16:30 | AMPHITHEATRE LAVOISIER - Level 1
Chair: Céleste LEBBE (France)
- Welcome and introduction - Céleste LEBBE (France)
- Cases and Conversations of Immunotherapy in Advanced CSCC - Céleste LEBBE (France), Axel HAUSCHILD (Germany), Michael MIGDEN (USA)
- Q&A and conclusions - Céleste LEBBE (France), Axel HAUSCHILD (Germany), Michael MIGDEN (USA)